Ideas Made to Matter
Fourteen MIT Sloan faculty members to follow on Twitter
New Twitter list collects insight and ideas from more than 40 professors, lecturers, and research scientists
Feb 19, 2015
Faculty
Zen Chu
Get in Touch
Title
About
Academic Groups
Academic Area
Centers & Initiatives
Zen Chu serves as Faculty Director of MIT's Hacking Medicine Initiative, and is a Senior Lecturer in Healthcare Innovation for both the MIT Sloan School of Management and Harvard-MIT Health Sciences & Technology program.
Zen actively consults companies in pharma, medical tech, corporate venture capital and healthcare systems adapting to global digital transformation.
In 2010, Professors Martha Gray ,Bill Aulet, and Zen created HST.978 MIT Healthcare Ventures, a graduate course that teaches medical artificial intelligence innovation, digital health models, generative Ai and venture capital investing. Healthcare Ventures has educated over one thousand physicians, MBAs, PhDs, engineers and startup founders in medical entrepreneurship. The course has been transplanted to UCLA and Yale Medical Schools.
As managing director of Accelerated Medical Ventures, Zen specializes in building early-stage medical technology and healthcare service companies, usually serving as cofounder and first investor. AMV’s portfolio spans Boston, Silicon Valley, and China, including PillPack.com, Abridge.com, Aptible.com, Figure1.com (acq), NuRx.com (acq), Apex Neuro (acq), 3D-Matrix Medical [JASDAQ: 7777], Sofi.com, Curoverse Genomics (acq), DirectDermatology.com, and a few companies still in stealth mode.
Alongside MIT professors Shuguang Zhang, Alex Rich, Alan Grodzinsky, and Bob Langer, Zen cofounded and served as CEO for 3D-Matrix Medical Inc., a venture-backed MIT regenerative medicine company with a successful IPO in 2011. 3D-Matrix has wound-healing and drug-delivery products on the market and multiple human clinical trials in process. Since then he has partnered with renowned scientists to co-found five medical technology companies.
He has managed and led new ventures for Harvard Medical School, Harvard’s Wyss Institute for Bioengineering, NetVentures, and Hewlett-Packard.
Zen earned a BS in biomedical/electrical engineering from Southern Methodist University and an MBA from Yale University.
MIT Industrial Liason Program Bio